Emilie R. W.
- Country
- France
- Department
- Medical Genetics
Research Overview
Data & Insights
Has run more than one trial at 0 of 10 partner sites.
Specializations
Hematologic Malignancies
The investigator concentrates on genetic and therapeutic aspects of Acute Myeloid Leukemia and related clonal disorders, emphasizing targeted strategies for high‑risk disease subsets.
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia
- Diffuse Large B‑Cell Lymphoma
Research integrates molecular profiling to refine risk stratification and guide novel immuno‑oncology approaches.
Solid Tumor Oncology
Key interests include precision medicine for Non‑Small Cell Lung Cancer, Renal Cell Carcinoma, and other advanced solid neoplasms, addressing driver mutations and resistance mechanisms.
- Non‑Small Cell Lung Cancer
- Renal Cell Carcinoma
- Hepatocellular Carcinoma
- Melanoma
- Triple‑Negative Breast Cancer
Efforts focus on integrating genomic biomarkers to personalize systemic and locoregional therapies.
Autoimmune and Systemic Disorders
Investigations target immune dysregulation in diseases such as Systemic Lupus Erythematosus, ANCA‑associated Vasculitis, and Myasthenia Gravis, exploring novel biologic agents.
- Systemic Lupus Erythematosus
- ANCA‑associated Vasculitis
- Myasthenia Gravis
- Crohn’s Disease
- Sjögren’s Syndrome
Emphasis is placed on genotype‑guided therapy and long‑term disease control.
Infectious and Pulmonary Conditions
Clinical work includes management of complex infections such as Nontuberculous Mycobacterial Lung Disease and chronic airway disorders like Obstructive Sleep Apnea.
- Nontuberculous Mycobacterial Lung Disease
- Obstructive Sleep Apnea
- Chronic Pulmonary Aspergillosis
- Bronchiectasis
- Mycobacterial Infections
Research aims to define optimal antimicrobial regimens and address host‑genetic susceptibility.
Cardiovascular and Metabolic Disorders
Focus areas encompass Atherosclerotic Cardiovascular Disease, hypertension, and metabolic risk factors including obesity and type‑2 diabetes.
- Atherosclerotic Cardiovascular Disease
- Hypertension
- Obesity
- Type‑2 Diabetes Mellitus
- Heart Failure
Efforts target integrated therapeutic pathways to mitigate cardiovascular events and metabolic complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.